⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 7, 2023Quality of Life ResearchOpen Access

Introduction to the special section: “Methodologies and considerations for meaningful change”

Andrew Trigg William R. Lenderking Jan R. Boehnke

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

AT declares current employment by

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Trigg et al. (2023) studied this question.

synapsesocial.com/papers/6a91a7e82678f30489935bf7 https://doi.org/10.1007/s11136-023-03413-1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Can Methods Developed for Interpreting Group-level Patient-reported Outcome Data be Applied to Individual Patient Management?Original Research · 2019 · 72 citations
2Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measuresSystematic Review · 2021 · 555 citations
3An overview of using qualitative techniques to explore and define estimates of clinically important change on clinical outcome assessmentsClinical Trial · 2019 · 84 citations
4A point of minimal important difference (MID): a critique of terminology and methodsOriginal Research · 2011 · 647 citations
5Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important changeOriginal Research · 2006 · 831 citations

Reliable change and the reliable change index: still useful after all these years?2022
Transitions in depression: if, how, and when depressive symptoms return during and after discontinuing antidepressants2022
Establishing thresholds for meaningful within-individual change using longitudinal item response theory2022
Prognostic associations between patient-reported outcomes and progression-free and overall survival in advanced gastric or gastroesophageal junction adenocarcinoma with PD-L1 TAP score ≥ 5%: results from the RATIONALE-305 trialQuality of Life Research · 2026
Patients with MASH experience worse health-related quality of life: a multinational real-world study using LiverMultiScanQuality of Life Research · 2026

More from Quality of Life Research

More from University of Dundee

More from Bayer (United Kingdom)